# A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

> **NCT04884997** · PHASE2 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 90 (estimated)

## Conditions studied

- Malignant Melanoma

## Interventions

- **DRUG:** toripalimab
- **DRUG:** Temozolomide Injection

## Key facts

- **NCT ID:** NCT04884997
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-07
- **Primary completion:** 2024-03-07
- **Final completion:** 2024-09-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04884997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04884997, "A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04884997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*